Book chapter
Clinical Management of Drug Use Disorders
DeckerMed Psychiatry
01/27/2021
DOI: 10.2310/PSYCH.13042
Abstract
Despite mammoth efforts toward the treatment and prevention of substance use disorders in the United States over the past 30 years, they remain a significant public health concern and an all-too-common comorbidity among people with other forms of mental illness. Continued research into genetics, pharmacotherapies, psychotherapies, and epidemiology for substance use disorders results in huge amounts of new information for clinicians to assimilate each year. This review summarizes current diagnostic and categorical standards in substance use disorders, epidemiology, genetic and physiologic factors in addiction for each class, clinically relevant laboratory testing, evidence-based treatments, and prognostic considerations in substance use disorders. Specifically, sections cover cannabinoids, hallucinogens, opioids, sedatives, and stimulants.
This review contains 3 figures, 6 tables and 60 references
Key words: benzodiazepines, cannabis, drug dependence, hallucinogens, MDMA, substance abuse, substance dependence, synthetic cannabinoids
Details
- Title: Subtitle
- Clinical Management of Drug Use Disorders
- Creators
- Alexander ThompsonTimothy AndoJames Jackson
- Resource Type
- Book chapter
- Publication Details
- DeckerMed Psychiatry
- DOI
- 10.2310/PSYCH.13042
- Language
- English
- Date published
- 01/27/2021
- Academic Unit
- Emergency Medicine; Psychiatry
- Record Identifier
- 9984296249602771
Metrics
50 Record Views